HomepageEarnings Events Newsdesk 1 day ago Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release Apollo Global Management Inc (APO) Siris Agrees to Acquire a Majority Stake in TAKKION from Apollo Funds » « Duke Energy Corporation (DUK) Duke Energy announces proposed offering of $1 billion of convertible senior notes due 2029 Newsdesk: